- Home
- Publications
- Publication Search
- Publication Details
Title
Biologic Drugs: A New Target Therapy in COPD?
Authors
Keywords
-
Journal
COPD-Journal of Chronic Obstructive Pulmonary Disease
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2018-04-24
DOI
10.1080/15412555.2018.1437897
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis
- (2017) Angira Dasgupta et al. EUROPEAN RESPIRATORY JOURNAL
- Benralizumab for the treatment of asthma
- (2017) Tara Vinyette Saco et al. Expert Review of Clinical Immunology
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
- (2017) Steven W. Yancey et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
- (2017) Ian D. Pavord et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tezepelumab in Adults with Uncontrolled Asthma
- (2017) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
- (2017) Peter J Castaldi et al. THORAX
- Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox
- (2017) Mathew Suji Eapen et al. Expert Review of Respiratory Medicine
- Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials
- (2016) Y. Cabon et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
- (2016) Nicola A Hanania et al. Lancet Respiratory Medicine
- IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk
- (2015) D. Kaur et al. ALLERGY
- Increased IL-33 expression in chronic obstructive pulmonary disease
- (2015) Jie Xia et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Epithelial cytokines and pulmonary allergic inflammation
- (2015) Clare M Lloyd et al. CURRENT OPINION IN IMMUNOLOGY
- Burden of smoking among adults with COPD, chronic bronchitis, and emphysema in urban China
- (2015) A. Goren et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The contribution of outdoor air pollution sources to premature mortality on a global scale
- (2015) J. Lelieveld et al. NATURE
- The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD
- (2015) A.M. Kirsten et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
- (2015) Leena George et al. Therapeutic Advances in Chronic Disease
- Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation
- (2014) K. Yadava et al. ALLERGY
- IL-33–Dependent Type 2 Inflammation during Rhinovirus-induced Asthma ExacerbationsIn Vivo
- (2014) David J. Jackson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy
- (2014) Corinne Cayrol et al. CURRENT OPINION IN IMMUNOLOGY
- Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
- (2014) M. Bafadhel et al. EUROPEAN RESPIRATORY JOURNAL
- Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease
- (2014) S. Ying et al. JOURNAL OF IMMUNOLOGY
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae
- (2014) Patrick Mallia et al. International Journal of Chronic Obstructive Pulmonary Disease
- Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
- (2014) Christopher E Brightling et al. Lancet Respiratory Medicine
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease
- (2012) Mona Bafadhel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial
- (2012) Shawn D Aaron et al. THORAX
- Function and mechanisms of TSLP/TSLPR complex in asthma and COPD
- (2011) N. S. Redhu et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
- (2011) Aarti Shikotra et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CCL20/CCR6 Feedback Exaggerates Epidermal Growth Factor Receptor-Dependent MUC5AC Mucin Production in Human Airway Epithelial (NCI-H292) Cells
- (2011) S. Kim et al. JOURNAL OF IMMUNOLOGY
- Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease
- (2011) John E. McDonough et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-1 pathways in inflammation and human diseases
- (2010) Cem Gabay et al. Nature Reviews Rheumatology
- Interleukin-13: prospects for new treatments
- (2009) C. E. Brightling et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Targeting TNF-α: A novel therapeutic approach for asthma
- (2007) Christopher Brightling et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease
- (2007) Samy Suissa et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now